EU/3/08/608

About

Please note that this product was withdrawn from the Union Register of orphan medicinal products in February 2020 on request of the sponsor.

On 6 February 2009, orphan designation (EU/3/08/608) was granted by the European Commission to Immunomedics GmbH, Germany, for Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1 for the treatment of pancreatic cancer.

Key facts

Active substance
Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1
Disease / condition
Treatment of pancreatic cancer
Date of first decision
06/02/2009
Outcome
Withdrawn
EU designation number
EU/3/08/608

Review of designation

Please note that this product was withdrawn from the Union Register of orphan medicinal products in February 2020 on request of the sponsor.

Sponsor's contact details

Immunomedics GmbH
Paul-Ehrlich-Str. 22/D1
63322 Rödermark
Germany
Tel. +49 61 51 66 715 66
E-mail: europe@immunomedics.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating